NDC 50228-431

Droxidopa

Droxidopa

Droxidopa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sciegen Pharmaceuticals Inc. The primary component is Droxidopa.

Product ID50228-431_bbb2d8e3-70b5-78f2-e053-2995a90a285e
NDC50228-431
Product TypeHuman Prescription Drug
Proprietary NameDroxidopa
Generic NameDroxidopa
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-02-18
Marketing CategoryANDA /
Application NumberANDA214017
Labeler NameScieGen Pharmaceuticals Inc
Substance NameDROXIDOPA
Active Ingredient Strength300 mg/1
Pharm ClassesCatecholamines [CS],Increased Blood Pressure [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50228-431-05

500 CAPSULE in 1 BOTTLE (50228-431-05)
Marketing Start Date2021-02-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Droxidopa" or generic name "Droxidopa"

NDCBrand NameGeneric Name
0054-0532DroxidopaDroxidopa
0054-0533DroxidopaDroxidopa
0054-0534DroxidopaDroxidopa
0832-0720DroxidopaDroxidopa
0832-0721DroxidopaDroxidopa
0832-0722DroxidopaDroxidopa
27241-199DroxidopaDroxidopa
27241-200DroxidopaDroxidopa
27241-201DroxidopaDroxidopa
27808-199droxidopadroxidopa
27808-200droxidopadroxidopa
27808-201droxidopadroxidopa
31722-010DroxidopaDroxidopa
31722-014DroxidopaDroxidopa
31722-015DroxidopaDroxidopa
50228-429Droxidopadroxidopa
50228-430Droxidopadroxidopa
50228-431Droxidopadroxidopa
59651-375DroxidopaDroxidopa
59651-376DroxidopaDroxidopa
59651-377DroxidopaDroxidopa
63304-086droxidopadroxidopa
63304-104droxidopadroxidopa
63304-112droxidopadroxidopa
67386-820Northeradroxidopa
67386-821Northeradroxidopa
67386-822Northeradroxidopa

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.